Treatment of caffeine toxicity with esmolol.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1688693.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present the case of a 58-year-old woman who ingested more than 35 g of caffeine in a suicide attempt. She manifested all the clinical symptoms and signs of caffeine toxicity. Esmolol, an ultrashort-acting beta 1-selective antagonist, controlled her multiple dysrhythmias and symptoms of sympathetic nervous system hyperstimulation. We suggest the use of esmolol for treatment of dysrhythmias secondary to caffeine toxicity; to the best of our knowledge, the use of esmolol has not been reported for this purpose.
Medical subject headings
- Adrenergic beta-Antagonists
- Caffeine
- Propanolamines
- Tachycardia, Supraventricular